| abstract |
Provided are novel immune inducing agents useful as cancer treatment and / or prophylactic agents. (A), (b) and (c) below, i.e., (a) a polypeptide consisting of 7 or more consecutive amino acids in an amino acid sequence represented by SEQ ID NO: 4, 2, 8, 10, 12 of the sequence table, (b) A polypeptide of polypeptide having at least 85% sequence identity with the polypeptide of (a) and consisting of seven or more amino acids, and (c) a polypeptide of the polypeptide comprising the polypeptide of (a) or (b) as a subsequence; In addition, an immune inducing agent comprising at least one polypeptide having immuno-inducing activity or a polynucleotide encoding the polypeptide and a recombinant vector capable of expressing the polypeptide in vivo as an active ingredient. |